Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.338NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.284ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.284ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.284ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.284NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.9.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.9.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.498ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.498ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.498ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.498NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.184ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.184ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.184ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.184NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.187ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.187ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.187ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.187NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
D.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
D.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
D.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
D.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AE.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AE.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.110.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.110.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.110.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.110.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.342ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.342ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.342ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.342NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.500ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.500ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.500ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.500NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.511ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.511ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.511ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.511NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.428.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.428.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.428.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.428.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.506ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used